Company
ybiologics.com
차세대 다중항체 신약 개발기업
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Seoul, South Korea
- Employees
- 48명 (2025년 06월 기준)Source (opens in a new tab)
- Legal name
- 와이바이오로직스
Claim, correct or request removal
Record updated 17 September 2026
About
Y-Biologics accumulates antibody-specialized technological capabilities through continuous antibody drug R&D activities and uses them to raise the company's competitiveness.
Funding snapshot
- Latest round
- Undisclosed2025-08-29
Funding rounds
- Round, 2025
- 2025-08-29
Loading relationship preview